A | THE ANSWER TO “WHEN” RANGES FROM OVERNIGHT TO NEVER. Some scientist entrepreneurs start companies and title themselves CEO while others spend their professional life without ever being offered a C-suite opportunity. Yet for most scientists who transition, timing is not a determinant variable but linked to the following critical factors.
When you can say “now” to all three, the timing is right, so go for it!
FRANCOIS NADER is chairman of Acceleron Pharma. The former CEO of NPS Pharma (acquired by Shire for $5.2 billion) now serves on several other corporate and philanthropy boards.